The US Food and Drug Administration (FDA) has approved GSK’s pentavalent meningococcal vaccine, Penmenvy, for children and ...

Tony Wood, Chief Scientific Officer, GSK, said: "We are excited about the opportunities ahead to help improve meningococcal vaccination coverage in the United States, especially for IMD caused by ...

GSK’s MenABCWY vaccine is an injectable suspension intended for intramuscular use. It comes with a vial of lyophilised ...

US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake ...

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals ...

GSK’s 5-in-1 meningococcal vaccine, Penmenvy receives US FDA approval to help protect against MenABCWY: London, UK Monday, February 17, 2025, 10:00 Hrs [IST] GSK plc announced t ...

European and US real estate asset manager and investor, Global Mutual, is delighted to announce that phase 1 of the retrofit ...

Blueprint Medicines (BPMC) sees strong AYVAKIT growth, 2025 revenue guidance at $680M-$710M. Discover insights on their market expansion & $2B 2030 vision.

Phase 1 of the retrofit development works of a 90,255 sq ft former GSK laboratory at its 28-acre life science campus, ...